NCT06813222View on ClinicalTrials.gov

Anemia-Related Outcomes in Patients With CKD Treated With Dapagliflozin

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions
AnemiaCKD
Interventions
DRUG

Dapagliflozin (DAPA)

Dapagliflozin 10 mg

Trial Locations (1)

22514

Damanhour University, Damanhur

All Listed Sponsors
lead

Damanhour University

OTHER